siRNA, Anti-TPM2, Ribo/Backbone-modified(CAT#: SIRGT21719WQ-RB)
The product SIRGT21719WQ-RB is a type of small interfering RNA (siRNA) that targets TPM2 gene and regulates the expression of gene. The siRNA interferes with the expression of TPM2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with Ribo modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_001301226.1; NM_001301227.1; NM_003289.3; NM_213674.1 |
| Alternative Names | AMCD1; DA1; DA2B; HEL-S-273; NEM4; TMSB |
| Related Diseases | Cap disease, nemaline myopathy |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT22719WQ-BB | TPM2 | Human | Backbone-modified |
